What is Wedbush’s Forecast for Vor Biopharma Q1 Earnings?
Vor Biopharma Inc. (NYSE:VOR – Free Report) – Equities research analysts at Wedbush issued their Q1 2026 earnings estimates for Vor Biopharma in a research report issued on Thursday, May 8th. Wedbush analyst D. Nierengarten forecasts that the company will post earnings of ($0.21) per share for the quarter. Wedbush currently has a “Neutral” rating […]
Vor Biopharma Inc. (NYSE:VOR – Free Report) – Equities research analysts at Wedbush issued their Q1 2026 earnings estimates for Vor Biopharma in a research report issued on Thursday, May 8th. Wedbush analyst D. Nierengarten forecasts that the company will post earnings of ($0.21) per share for the quarter. Wedbush currently has a “Neutral” rating […]
